Screened 2026-09-10 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markup label.
Trimble Inc. holds its Markup at $56.84. The statistical read favours the sellers, held for 13 days.
As held on the ledger · 2026-09-10
Phase
Markup
Quantitative state
The statistical read favours the sellers, held for 13 days
Price at the screen
$56.84
Valuation
N/A trailing · 13.78 forward price to earnings
Values screen
PASS· score 88.9
Beta
1.36
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
14.95%
Below 33%
Interest-bearing debt is just 15.0% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
6.56%
Below 33%
Cash held in interest-bearing accounts and securities is 6.6% of assets, under the one-third limit.
Pass
Receivables
11.91%
Below 49%
Money owed to the company is 11.9% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads OPPORTUNITY: it trades at roughly a 27% discount to our $72.37 fair value, narrow competitive moat, 11.00% revenue growth.
Fair value range in USD, drawn from the 2026-09-10 screen. The gold marker is the market price at the same screen. A 27.3% margin of safety to the base estimate.
Third-party analyst targets: 11 covering, consensus None. The average target sits +41% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-10 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Construction sites finally get joined up tech
Picture a surveyor on site whose measurements flow straight into the architect's model without a single spreadsheet in between. Trimble stitches those workflows together across building, agriculture and transport, and the numbers show it scaling nicely. Revenue is rising 12 percent a year, margins sit at 12 percent, and the shares trade on just 12.9 times forward earnings against a fair value that implies 78 percent upside.
The narrow moat and 8 percent return on equity keep expectations realistic, yet the ethical screen is clean and twelve analysts still cluster around an 82 dollar median target. At 52.72 dollars the valuation leaves room for steady compounding if execution holds.
Cyclical end markets can still bite when project spending slows, and the modest profitability means any slip in growth would compress the multiple quickly. Analysis, not advice.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
TRMB trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-15Markup · changed$58.55+8.0%Entry 4
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 8.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 30%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (12 analysts) rates it strong buy, with a mean price target of $87.
2026-07-18Distribution$54.19+0.0%Entry 3
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 30%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (12 analysts) rates it strong buy, with a mean price target of $87.
2026-07-03Distribution$54.19+0.0%Entry 2
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns.
2026-07-02Distribution$54.19Entry 1
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
